Bristol-Myers Squibb News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

01.12.16	InvestorsObserver releases covered-call reports for Netflix, Cisco Systems, Apache Corporation, Bristol-Myers Squibb and Caterpillar Inc. (PR Newswire)
18.11.16	Research Reports on Drug Makers Equities -- Bristol-Myers Squibb, AstraZeneca, TherapeuticsMD, and Tonix Pharma (PR Newswire)
16.11.16	Bristol-Myers Squibb And Enterome Announce Immuno-Oncology Collaboration (RTTNews)
11.11.16	ANTH Plunges As Lupus Trial Fails, BMY's Opdivo Is At It Again, FDA Nod For GILD (RTTNews)
11.11.16	Bristol-Myers : FDA Oks Opdivo For Treatment Of Recurrent Or Metastatic SCCHN (RTTNews)
10.11.16	Bristol-Myers Squibb: Opdivo Meets Primary Endpoint Of Overall Survival (RTTNews)
31.10.16	Bristol-Myers Announces New Data Presentations From Studies Evaluating Opdivo (RTTNews)
27.10.16	Bristol-Myers Rising Sharply On Upbeat Q3 Results, Guidance (RTTNews)
27.10.16	Biotech Stocks Facing FDA Decision In November (RTTNews)
27.10.16	Bristol-Myers Q3 Results Top View; Ups FY16 Forecast; To Buy Back $3 Bln Shares (RTTNews)
27.10.16	Bristol-Myers Squibb Co. Earnings Advance 99% In Q3 (RTTNews)
24.10.16	BMY's Opdivo At The Altar Again, MRK Gets FDA Nod, Watch Out For OASM (RTTNews)
14.10.16	Bristol-Myers: CHMP Recommends Approval Of Opdivo - Quick Facts (RTTNews)
10.10.16	Bristol-Myers Squibb: Phase 3 Studies Experienced Ongoing Responses With Opdivo (RTTNews)
27.09.16	Bristol-Myers, Nektar Collaborate To Evaluate Combination Of Opdivo And NKTR-214 (RTTNews)
20.09.16	Bristol-Myers' Type II Variation Application For Opdivo Validated By EMA (RTTNews)
06.09.16	Bristol-Myers Squibb Gets EU Approval For Orencia For Rheumatoid Arthritis (RTTNews)
08.08.16	DVAX To Face FDA Panel, BMY's Opdivo Disappoints, MRK Scores Big With FDA Nod (RTTNews)
05.08.16	Bristol-Myers:Opdivo Fails To Meet Primary Endpoint Of Progression-free Survival (RTTNews)
28.07.16	Bristol-Myers Squibb Lifts FY16 Earnings View As Q2 Results Top Estimates (RTTNews)
28.07.16	Bristol-Myers Squibb Co. Announces 30% Advance In Q2 Earnings (RTTNews)
26.07.16	Bristol-Myers In New Clinical Research Collaboration With Janssen Biotech (RTTNews)
25.07.16	Bristol-Myers Reports CHMP's Recommendation For ORENCIA - Quick Facts (RTTNews)
25.07.16	AbbVie, Bristol-Myers Announce Oncology Clinical Collaboration - Quick Facts (RTTNews)
20.07.16	Bristol-Myers Squibb Launches ORENCIA ClickJect Autoinjector - Quick Facts (RTTNews)
19.07.16	EVOK Runs Out Of Gas, ELOS Gets FDA Nod, 1 Down, 1 To Go For CYNA, BCLI Abuzz (RTTNews)
18.07.16	Bristol-Myers Announces U.S. And European Submissions For Expanded Use Of Opdivo (RTTNews)
05.07.16	Bristol-Myers Buys Privately-Held Cormorant Pharmaceuticals - Quick Facts (RTTNews)
30.06.16	PsiOxus, Bristol-Myers Squibb To Evaluate Combination Of Opdivo, Enadenotucirev (RTTNews)
07.06.16	Bristol-Myers, MD Anderson Announce Research Collaboration In Immuno-Oncology (RTTNews)
06.06.16	Bristol-Myers Reports Results From Trials On Opdivo And Yervoy (RTTNews)
05.06.16	Bristol-Myers Squibb : Long-Term Survival Observed With Opdivo In Advanced RCC (RTTNews)
18.05.16	Bristol Myers' Opdivo - A Pipeline In Itself... (RTTNews)
12.05.16	All Eyes On CTIX, Busy Days Ahead For KURA, Make-or-Break Events Await CYNA (RTTNews)
28.04.16	Bristol-Myers Lifts FY16 Profit View; Stock Up (RTTNews)
28.04.16	Bristol-Myers Squibb Co. Q1 Earnings Advance 4% (RTTNews)
25.04.16	Bristol-Myers Squibb: FDA Grants Breakthrough Therapy Designation To Opdivo (RTTNews)
15.04.16	D-Day Awaits CHMA, APHB Abandons XON Collaboration, More On The Way For Opdivo (RTTNews)
14.04.16	Bristol-Myers: FDA Accepts For Priority Review SBLA For Opdivo - Quick Facts (RTTNews)
07.04.16	BIND In A Fix, APRI To File NDA In Q3, TSRO Abuzz (RTTNews)
23.03.16	Bristol-Myers Squibb To Acquire Padlock - Quick Facts (RTTNews)
07.03.16	Bristol-Myers To Partner With LabCentral To Support Biotech Startup Companies (RTTNews)
29.02.16	Man(n)kind Loses A Visionary, FDA Expands Gazyva's Use, Binary Events Await PTLA (RTTNews)
22.02.16	Bristol-Myers Reports Positive Data From HCV Regimen Phase 3 Trial - Quick Facts (RTTNews)
08.02.16	Trouble For CTIC, It's A Thumbs Up For BMY, CYCC On Notice Again, VRTX Snubbed (RTTNews)
01.02.16	Bristol-Myers, Pfizer Join With Portola To Develop Andexanet Alfa In Japan (RTTNews)
29.01.16	Bristol-Myers And AbbVie Receive Positive CHMP Opinion For Empliciti (RTTNews)
28.01.16	Bristol-Myers Squibb Stops Randomized Phase 3 Trial Early (RTTNews)
28.01.16	Bristol-Myers Squibb Co. Q4 Income Falls 16% (RTTNews)
25.01.16	BMY's Opdivo Scores Another FDA Nod, INO To Take A Shot At Zika, OMED On Watch (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’263.50	2.89 %	K V
Sonova Hldg	312.10	2.66 %	K V
Novartis	93.68	2.32 %	K V
Geberit	526.80	1.97 %	K V
Roche Hldg G	254.30	1.27 %	K V
Kuehne+Nagel Int	209.50	0.72 %	K V
UBS Group	28.30	0.57 %	K V
Givaudan	3’933.00	0.36 %	K V
Nestle	76.00	0.05 %	K V
Lonza Grp	521.40	-0.04 %	K V

mehr

22.11.24		Dow Jones aktuell: Dow Jones zum Ende des Freitagshandels in der Gewinnzone
22.11.24		SIX-Handel: SLI zeigt sich zum Ende des Freitagshandels fester
22.11.24		Pluszeichen in Zürich: SMI zum Ende des Freitagshandels mit grünem Vorzeichen
22.11.24		Gute Stimmung in Europa: Anleger lassen STOXX 50 letztendlich steigen
22.11.24		Deutsche Bank AG: Novartis-Aktie erhält Hold
22.11.24		Freitagshandel in New York: Dow Jones zum Start des Freitagshandels fester
22.11.24		Optimismus in Europa: So entwickelt sich der Euro STOXX 50 am Freitagnachmittag
22.11.24		Pluszeichen in Europa: STOXX 50 notiert im Plus

22.11.24

Dow Jones aktuell: Dow Jones zum Ende des Freitagshandels in der Gewinnzone

22.11.24

SIX-Handel: SLI zeigt sich zum Ende des Freitagshandels fester

22.11.24

Pluszeichen in Zürich: SMI zum Ende des Freitagshandels mit grünem Vorzeichen

22.11.24

Gute Stimmung in Europa: Anleger lassen STOXX 50 letztendlich steigen

22.11.24

Deutsche Bank AG: Novartis-Aktie erhält Hold

22.11.24

Freitagshandel in New York: Dow Jones zum Start des Freitagshandels fester